Non-alcoholic fatty liver disease and diabetes.

Non-alcoholic fatty liver disease and diabetes.

Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and can act synergistically to drive adverse outcomes. The presence of both NAFLD and T2DM increases the likelihood of the development of complications of diabetes (including both macro...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hazlehurst, J, Woods, C, Marjot, T, Cobbold, J, Tomlinson, J
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2016

Ítems similars

Glucocorticoids and non-alcoholic fatty liver disease.
per: Woods, C, et al.
Publicat: (2015)

Non-alcoholic fatty liver disease in common endocrine disorders.
per: Hazlehurst, J, et al.
Publicat: (2013)

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
per: Marjot, T, et al.
Publicat: (2019)

Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
per: Marjot, T, et al.
Publicat: (2017)

Non-alcoholic fatty liver disease
per: Pavlides, M, et al.
Publicat: (2019)

Pathogenesis of non-alcoholic fatty liver disease.
per: Dowman, J, et al.
Publicat: (2010)

The diagnosis of non-alcoholic fatty liver disease: authors' reply
per: Dowman, J, et al.
Publicat: (2012)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
per: Dowman, J, et al.
Publicat: (2011)

Current therapeutic strategies in non-alcoholic fatty liver disease.
per: Dowman, J, et al.
Publicat: (2011)

Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.
per: Armstrong, M, et al.
Publicat: (2014)

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome.
per: Gathercole, L, et al.
Publicat: (2016)

Non-alcoholic fatty liver disease in obese persons with diabetes
per: Tomašević Ratko, et al.
Publicat: (2007-01-01)

Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
per: Mathew Jacob, et al.
Publicat: (2023-09-01)

Non-Alcoholic Fatty Liver Disease: The Silent Epidemic
per: J. M. R. P. Bandara
Publicat: (2024-04-01)

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
per: Sheridan, D, et al.
Publicat: (2017)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
per: L.V. Chistova, et al.
Publicat: (2010-11-01)

Curcumin and non-alcoholic fatty liver disease
per: Nasrin Sharifi, et al.
Publicat: (2024-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
per: L.V. Chistova, et al.
Publicat: (2010-11-01)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
per: Pavlides, M, et al.
Publicat: (2017)

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
per: Marium Ahmed, et al.
Publicat: (2024-04-01)

Trend of Non-Alcoholic Fatty Liver Disease in Type II Diabetes Mellitus
per: Fariha Khan, et al.
Publicat: (2024-05-01)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
per: Preya J. Patel, et al.
Publicat: (2017-01-01)

Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome
per: Moolla, A, et al.
Publicat: (2020)

Arterial stiffness in non-alcoholic fatty liver disease
per: T.V. Chendey, et al.
Publicat: (2024-06-01)

Gut microbiome in non-alcoholic fatty liver disease
per: Anastasios Mpountouridis, et al.
Publicat: (2025-01-01)

Genetic Aspects of Non-Alcoholic Fatty Liver Disease
per: Pavel O. Bogomolov, et al.
Publicat: (2019-01-01)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
per: Saira Rafaqat, et al.
Publicat: (2024-03-01)

Non-alcoholic fatty liver disease and cognitive impairment
per: Elena V. Onuchina, et al.
Publicat: (2024-12-01)

Improvement of non-alcoholic fatty liver disease treatment
per: P. I. Seliverstov, et al.
Publicat: (2014-10-01)

New aspects of non-alcoholic fatty liver disease
per: V. V. Tsukanov, et al.
Publicat: (2015-09-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
per: D. V. Blinov
Publicat: (2015-12-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
per: A. E. Bagriy, et al.
Publicat: (2021-06-01)

Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease
per: Sonal Kumar, et al.
Publicat: (2024-04-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
per: M. V. Mayevskaya, et al.
Publicat: (2018-11-01)

A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease
per: Ahmed, A, et al.
Publicat: (2012)

Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
per: Samar A. Zailaie, et al.
Publicat: (2024-01-01)

Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants
per: Robert Maidstone, et al.
Publicat: (2024-01-01)

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
per: Masahiro Kikuchi, et al.
Publicat: (2024-09-01)

Association between toothbrushing and non-alcoholic fatty liver disease.
per: Ji-Youn Kim, et al.
Publicat: (2021-01-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
per: Evgenia Pavlovna Kosobyan, et al.
Publicat: (2010-03-01)